Kindly MD NAKA

Kindly MD Q1 FY25: revenue $580K; diluted EPS −$0.17

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.20
Material contract

Key figures from this report

These are the numbers Kindly MD reported for Q1 FY25, the quarter ended Mar 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$580KNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income−$1.0MAgainst −$282K in Q1 FY2410-Q income statement, on EDGAR
  3. Diluted EPS−$0.17Against −$0.06 in Q1 FY2410-Q income statement, on EDGAR
  4. Cash and cash equivalents$1.1M+297% from $287K in Q1 FY2410-Q balance sheet, on EDGAR
  5. Cash from operations−$865KAgainst −$213K in Q1 FY2410-Q cash flow statement, on EDGAR

Every quarter in the financial tables

Get an email when Kindly MD files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6199 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.